In addition to using IL-15 and its agonists alone in cancer immunotherapy, IL-15 has been incorporated into many cancer-specific pericyte therapies, particularly in combination with chimeric antigen receptor (CAR) engineering. The gene discussed is IL15; the disease is cancer.